Clinical Trials Sponsored by Ligand Pharmaceuticals
Total 19959 results
-
Ligand PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Ligand PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Ligand PharmaceuticalsCompletedSeasonal Allergic RhinitisCanada
-
Ligand PharmaceuticalsCompleted
-
Ligand PharmaceuticalsCompletedHypertensionUnited States
-
Ligand PharmaceuticalsCompletedBone LossUnited Kingdom
-
Ligand PharmaceuticalsCompletedOsteoporosisTaiwan, Japan, Korea, Republic of
-
Ligand PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Ligand PharmaceuticalsCompletedEarly Stage Parkinson's DiseaseUnited States
-
Ligand PharmaceuticalsCompletedRestless Legs SyndromeUnited States
-
Ligand PharmaceuticalsCompletedHypertensionUnited States
-
Ligand PharmaceuticalsCompletedOsteoporosisUnited States, Australia, Canada, Costa Rica, Germany, Russian Federation, France, Croatia, South Africa, Belgium, Japan, India, Spain, United Kingdom, Italy, Egypt, Turkey, Lithuania, Poland, Norway, Estonia, Finland, Denmark, Hong Kong and more
-
Ligand PharmaceuticalsWithdrawn
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
Ligand PharmaceuticalsCompleted
-
Nucorion Pharmaceuticals, Inc.Ligand PharmaceuticalsCompletedChronic Hepatitis BUnited States
-
Ligand PharmaceuticalsCyDex Pharmaceuticals, Inc.Withdrawn
-
Ligand PharmaceuticalsMedpace, Inc.CompletedType 2 Diabetes Mellitus (T2DM)United States
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Stanford UniversityAstraZeneca; Ligand PharmaceuticalsCompleted
-
Nucorion Pharmaceuticals, Inc.Medpace, Inc.; Ligand PharmaceuticalsCompletedHepatitis BUnited States
-
CyDex Pharmaceuticals, Inc.Syneos Health; Ligand PharmaceuticalsCompletedContrast-induced Nephropathy | Coronary AngiographyCanada
-
Ligand PharmaceuticalsCompleted
-
Ligand PharmaceuticalsCompletedLymphoma | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Fox Chase Cancer CenterLigand PharmaceuticalsTerminatedParapsoriasisUnited States
-
M.D. Anderson Cancer CenterLigand PharmaceuticalsCompletedAlopecia AreataUnited States
-
Ligand PharmaceuticalsMedpace, Inc.; Beckloff Associates, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand PharmaceuticalsCompletedAdvanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)United States
-
Ligand PharmaceuticalsCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand PharmaceuticalsCompletedCarcinoma, Non-small-cell LungUnited States
-
Lundbeck LLCQuintiles, Inc.; ICON Clinical Research; Ligand PharmaceuticalsCompleted
-
Dartmouth-Hitchcock Medical CenterBristol-Myers Squibb; Ligand PharmaceuticalsTerminatedCarcinoma, Non-small-cell LungUnited States
-
Konstantin DragnevGenentech, Inc.; Ligand PharmaceuticalsCompletedCarcinoma, Non-small-cell LungUnited States
-
Efferon JSCLigand Research, LLCCompleted
-
Pharmtechnology LLCLigand Research, LLCCompleted
-
Pharmtechnology LLCLigand Research, LLCCompletedBioequivalenceRussian Federation
-
Anderson Clinical ResearchLigand PharmaceuticalsCompletedHIV Infections | Sarcoma, Kaposi
-
Efferon JSCLigand Research, LLCRecruitingSepsis | Septic ShockRussian Federation
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Anderson Clinical ResearchLigand PharmaceuticalsCompletedHIV Infections | Sarcoma, Kaposi
-
Pharmaceutical Research Unit, JordanSanofi-aventis Liban SALWithdrawn
-
Legend Labz, Inc.Recruiting
-
University of LuganoCompletedGroup 1 (Control): Access to a Static Version of the Website Containing Only Static Features (i.e. Library, First Aid, and FAQ) | Group2 (Intervention) Access to an Interactive Version of the Website Containing Both Static and Interactive FeaturesSwitzerland
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Legend Labz, Inc.RecruitingSafety IssuesUnited States
-
University of Medicine and Dentistry of New JerseyLigand PharmaceuticalsCompleted
-
Tyligand Bioscience (Shanghai) LimitedRecruitingHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaChina
-
Ospedale Regionale di LuganoRecruitingNeuropathy Small FibreSwitzerland